Home  |  Careers  |  Contact Us  |  Sitemap
About
Getz Pharma
  Research &
Development
  Business
Partnerships
  Marketing &
Sales
  Technical
Operations
  Products   Getz Pharma Cares

Back

Iron (III)-hydroxide polymaltose complex + Folic acid

Country:  

Therapeutic Segment

Hematinic

Generic Name

Iron (III)-hydroxide polymaltose complex + Folic acid

Indication

It is indicated for: The treatment of latent iron deficiency; manifest iron deficiency; prophylactic therapy of iron and folic acid deficiency before during and after pregnancy (during lactation).


Brands

Ferfix-FA

Form

Tablets

(Hover on images to enlarge)

Home :  Legal
©2014 Getz Pharma (Pvt) Ltd.

Site Powered by USFI